Jan. 14, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system ...

MICHELLE RENEE GRIFFIN, a director at $ADPT, sold 36,291 shares of the company on 03-13-2025 for an estimated $260,932. We received data on the trade from a recent ...

Investors in Adaptive Biotechnologies Corp (Symbol: ADPT) saw new options become available this week, for the October 17th expiration. One of the key data points that goes into the price an option ...

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report)’s stock price fell 6.1% on Thursday after an insider sold shares in the company.The company traded as low as $7.46 and last traded ...

In a report released yesterday, Justin Zelin from BTIG reiterated a Buy rating on Adaptive Biotechnologies (ADPT – Research Report), with a price target of $10.00. The company’s shares closed ...

Adaptive Biotechnologies (ADPT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

In this article, we are going to take a look at where Flagstar Financial, Inc. (NYSE:FLG) stands against other firms buck market slump on impressive earnings, new deals. The stock market ended the ...

In this article, we are going to take a look at where Adaptive Biotechnologies Corporation (NASDAQ:ADPT) stands against the other stocks that are skyrocketing now. The market has started to favor ...

Read Our Latest Stock Analysis on ADPT Adaptive Biotechnologies Trading Down 5.4 % The company has a market cap of $1.08 billion, a price-to-earnings ratio of -6.74 and a beta of 1.53. The company ...

The value of this trade, calculated from the latest closing price is over $1.75 million. The MELI and ADPT Trades On the same day, Ark Invest also sold shares of MercadoLibre Inc and Adaptive ...